We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Psychedelics – News and Features

A collection of growing mushrooms.

How Psychedelic Therapies Can Be Used in Practise in Treating Mental Health Conditions

The exploration of alternative therapeutics for hard-to-treat mental health disorders has brought into focus an array of psychedelics such as psilocybin, present in ‘magic mushrooms’, and LSD, substances once associated more with counterculture than clinical practice.
Tabs of paper lit by a rainbow.

Multiple Psychedelic Drugs Can Reopen the Critical Period for Socializing in Mice

A new study conducted at the lab in mice suggests that multiple psychedelic drugs are capable of reopening "critical periods" in the brain for durations stretching from just a couple of days through to a full month.
White pills on a blue background.

MDMA Approved for Schizophrenia Clinical Trial by FDA

The FDA has approved the use of an MDMA investigational medical product in a small clinical trial to assess its tolerability in a small number of patients with schizophrenia.
A glass vial surrounded by psychedelic mushrooms.

Non-LSD Hallucinogen Use on the Rise

Young adults ages 19 to 30 nearly doubled their past 12-month use of non-LSD hallucinogens in the United States from 2018 to 2021.
A psychedelic pattern

Study Shows How Psychedelic Drugs Rewire the Brain

A new study has revealed details about how the psychedelic drugs LSD and psilocin – the active ingredient in magic mushrooms – bind to receptors in the brain.
A psychedelic pulse line.

The Pulse: Psychedelic News From Technology Networks Issue 4

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
A computer-generated image of a brain with multicolored strands emerging from the sides.

Ketamine Matches ECT Efficacy for Treating Major Depression, Study Suggests

In a clinical trial of 403 patients, researchers found that 55% of those who received ketamine treatment experienced sustained improvements in depressive symptoms without major side effects.
Two strawberries side by side in transparent, round dishes showing one is more well preserved than the other.

Strawberry's Shelf Life Could Be Extended With a CBD Coating

To increase the shelf life of strawberries, researchers have incorporated cannabidiol — a non-hallucinogenic compound from cannabis known as CBD — and sodium alginate into an edible antimicrobial coating.
Plastic model of the right hemisphere of a human brain.

Lack of Oxytocin Proved in People With a Vasopressin Deficiency

Researchers have shown that people with vasopressin deficiency have an oxytocin deficiency as a result of a disease of the pituitary gland.
Psilocybin mushrooms.

Why Indigenous Principles Should Be Adopted by Modern Psychedelic Psychiatry

A new study explores how Western institutions can ethically approach the growing research and use of psychedelics as viable medical therapies.